These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6960319)

  • 1. [Fall in the levels of circulating lymphoblasts caused by intravenous administration of the A50 monoclonal antibody in a patient with acute T-cell lymphoblastic leukemia. A step in the demonstration of serotherapy with monoclonal antibodies].
    Bernard A; Gosse C; Pico J; Faure E; Raynal B; Hayat M; Lemerle J; Charbord P; Boumsell L
    Nouv Presse Med; 1982 Oct; 11(43):3173-8. PubMed ID: 6960319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
    Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.
    Ritz J; Pesando JM; Sallan SE; Clavell LA; Notis-McConarty J; Rosenthal P; Schlossman SF
    Blood; 1981 Jul; 58(1):141-52. PubMed ID: 6786392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
    Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a monoclonal antibody recognizing an epitope designated as canine leukocyte-associated antigen.
    Yang WC; Esquenazi V; Carreno M; Vallone T; Fuller L; Roth D; Nery J; Burke G; Miller J
    Transplantation; 1994 Jul; 58(2):233-40. PubMed ID: 7518977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK
    Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen.
    Nadler LM; Stashenko P; Hardy R; Kaplan WD; Button LN; Kufe DW; Antman KH; Schlossman SF
    Cancer Res; 1980 Sep; 40(9):3147-54. PubMed ID: 7427932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
    Greaves MF; Janossy G; Peto J; Kay H
    Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro.
    Bieber MM; Twist CJ; Bhat NM; Teng NN
    Pediatr Blood Cancer; 2007 Apr; 48(4):380-6. PubMed ID: 16421902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
    Retter MW; Johnson JC; Peckham DW; Bannink JE; Bangur CS; Dresser K; Cai F; Foy TM; Fanger NA; Fanger GR; Woda B; Rock KL
    Cancer Res; 2005 Jul; 65(14):6425-34. PubMed ID: 16024647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guinea pig line 10 hepatocarcinoma model for monoclonal antibody serotherapy: in vivo localization of a monoclonal antibody in normal and malignant tissues.
    Key ME; Bernhard MI; Hoyer LC; Foon KA; Oldham RK; Hanna MG
    J Immunol; 1983 Mar; 130(3):1451-7. PubMed ID: 6185590
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.
    Sanna PP; De Logu A; Williamson RA; Hom YL; Straus SE; Bloom FE; Burton DR
    Virology; 1996 Jan; 215(1):101-6. PubMed ID: 8553581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody specific for human T acute lymphoblastic leukaemia.
    Deng C; Terasaki P; Chia J; Billing R
    Lancet; 1982 Jan; 1(8262):10-1. PubMed ID: 6119411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
    Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
    Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD(45)RB monoclonal antibody induces immunologic toleration by suppressing dendritic cells.
    Xia X; Zhang X; Huang X; Ichim TE; Li M; Luke P; Min W
    Transpl Immunol; 2009 Jul; 21(3):136-9. PubMed ID: 19389475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface markers in acute lymphoblastic leukemia.
    Humphrey GB; Blackstock R; Filler J
    Ann Clin Lab Sci; 1980; 10(3):169-80. PubMed ID: 6967278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
    Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.